Gene · 2621
NIH grants2,018
NIH grants whose papers are about the gene, through NIH's grant-paper links.
1,261 to 1,280 of 2,018
Download this page as JSON| Grant | Title | GAS6 papers | Newest fiscal year |
|---|---|---|---|
| F31ES027301 | The role of beta-endorphin in cutaneous inflammation | 1 | 2017 |
| F99CA212229 | Investigating degradation as a therapeutic strategy against the Pseudo-kinase KSR | 1 | 2017 |
| F99CA212456 | New therapeutic opportunities from mining polypharmacology mechanisms of ceritinib in ALK-negative non-small cell lung cancer | 1 | 2017 |
| G12MD007582 | FAMU RCMI Pharmaceutical Research Center | 1 | 2017 |
| G12MD007602 | Morehouse School of Medicine G12 Multidisciplinary Biomedical Research Center | 1 | 2017 |
| I01BX000513 | Human neutrophils and Staphylcoccus aureus: microbial targets and responses | 1 | 2017 |
| I01BX001994 | An FGFR1 oncogene driver pathway in head and neck cancer | 1 | 2017 |
| K08CA187577 | Investigating Resistance to FLT3 Inhibitors in AML | 1 | 2017 |
| K24CA172355 | Enhancing Translational Science via Prospective Investigation | 1 | 2017 |
| K99CA207744 | Single Cell In Vivo Imaging Technology to Analyze Taxane Nano Formulations in Breast Cancer | 1 | 2017 |
| K99CA208028 | Investigating the role of RBM10-regulated alternative splicing in lung tumorigenesis | 1 | 2017 |
| KL2TR001100 | Harvard Clinical and Translational Science Center | 1 | 2017 |
| P01CA168585 | Overcoming BRAF-inhibitor Resistance in Melanoma | 1 | 2017 |
| P01HL088594 | Role of Eosinophils in Airway Inflammation and Remodeling | 1 | 2017 |
| P50CA090381 | DF/HCC SPORE in Prostate Cancer | 1 | 2017 |
| P50CA095103 | SPORE in GI Cancer | 1 | 2017 |
| P50HG004233 | Genomic Analysis of Network Perturbations in Human Disease | 1 | 2017 |
| R00CA175290 | An integrated approach to dissect the functional network of large non-coding RNA | 1 | 2017 |
| R00HL119587 | Specialized pro-resolving mediators in atherosclerosis | 1 | 2017 |
| R00LM011673 | Developing Graph Models and Efficient Algorithms for the Study of Cancer Disease | 1 | 2017 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2621/grants?page=64